Navigation Links
Oh, rats! Designer animals reveal possible heart disease genes

Every year, heart disease claims an estimated 7 million lives, according to the World Health Organization. Scientists have struggled to pinpoint the precise genes behind this complex disease. Now, however, they have a new research ally: the designer rat.

In a four-year study published in the January 15 advance online publication of Nature Genetics, researchers at The Institute for Genomic Research (TIGR) and the Medical College of Wisconsin (MCW) systematically bred and studied 43 designer rats with and without high blood pressure, in order to pinpoint candidate genes behind heart disease. In total, the scientists built 2,200 microarray gene expression profiles from these designer rats--providing a valuable new online resource now available to researchers worldwide.

Scientists have long used rat models to study heart disease in the lab. But those studies have yet to answer key questions: Which genes, on which chromosomes, combine to cause this complex condition? Why, and how, do some animals become hypertensive when consuming high-salt diets, while others stay healthy? To turn the tools of genomics onto these questions, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, funded the new study.

In the first part of the study, MCW researchers began with a strain of rats bearing high blood pressure, a hallmark of heart disease. The researchers then bred an almost identical designer rat, with one important change: they substituted one chromosome from the parental, hypertensive rat with the homologous chromosome from a healthy rat. Continuing this way, the team generated 22 unique designer rat strains, each bearing one distinct healthy chromosome substitution. Some of these new designer rats were disease-free, implying that their replaced chromosomes carried genes for high blood pressure and related conditions.

In the second part of the study, TIGR molecular biologist Norman Lee led the team in using a DNA microarray technique to compare the expression of more than 22,000 genes among the hypertensive, healthy, and designer rats. By studying the physical characteristics and gene expression of more than 800 rats, the team identified candidate genes that may contribute to cardiovascular disease, including some genes not previously associated with the condition.

"This information offers an unprecedented amount of data for cardiovascular researchers to now mine," remarks Lee, senior author of the study. Lead author Renae Malek, also a molecular biologist at TIGR, notes that the data point to promising genes for salt-sensitive hypertension, among other conditions. The online database resulting from the study, dubbed TREX, is available free of charge at: http://pga.tigr.org/.

TIGR continues to study the panels of designer rat strains, and Lee hopes in the future to knock out specific candidate heart disease genes, directly testing their effects. "With all this information in hand, science is moving from a microscopic to global perspective of heart disease," Lee says. "This will generate research projects for years down the line."


'"/>

Source:The Institute for Genomic Research


Related biology news :

1. Designer babies - what would you do for a healthy baby?
2. Plants, animals share molecular growth mechanisms
3. Elephants imitate truck noises, other animals
4. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
5. Gene therapy for Parkinsons disease moves forward in animals
6. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
7. Undesirable expatriates: Preventing the spread of invasive animals
8. Two new retroviruses—transmitted from animals—identified
9. Stem cell therapy successfully treats heart attack in animals
10. More animals join the learning circle
11. Proposal would allow wild animals to roam North America
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/22/2016)... -- According to the new market research report "Biometric System ... Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, and ... expected to grow from USD 10.74 Billion in 2015 to reach USD ... 2022. Continue Reading ... ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016  Vyriad Inc. announced today the ... company,s Board of Directors. "We are delighted ... our business and develop our oncolytic viruses as the ... Stephen Russell , MD, PhD, CEO of Vyriad. ... our vision and passion for making a difference for ...
(Date:12/7/2016)... DIEGO , December 7, 2016 ... in the International Journal of Molecular Sciences a team of ... 1 ] have demonstrated that expression of NR2F6 ...  These scientists tested for NR2F6 in patient,s cervical cancer tissue ... their tumors. "This is an interesting study and ...
(Date:12/7/2016)... , ... December 07, 2016 ... ... opening applications to an early access program for SmartBiome -- a novel ... with the simultaneous specific enrichment and detection of hundreds of different genes. ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... largest privately-held contract pharmaceutical development and manufacturing organisation, today announced the ... company combining a leading CRO and the industry’s only Contract Commercial Organization ...
Breaking Biology Technology: